Latest Health News

Page 7 of 212
ActivEX Limited has fully repaid its $2.3 million loan to Star Diamond Developments by transferring full ownership of its East Coast Gold and Copper subsidiary, leaving the company debt free and financially strengthened.
Maxwell Dee
Maxwell Dee
10 Mar 2026
OzAurum Resources has secured environmental approval for Stage 1 of its Mulgabbie North Gold Project, clearing a major regulatory hurdle and accelerating its path to near-term production.
Maxwell Dee
Maxwell Dee
10 Mar 2026
FleetPartners Group Limited has announced a $20 million on-market share buy-back, reinforcing its strong balance sheet and commitment to shareholder returns alongside its existing dividend policy.
Claire Turing
Claire Turing
10 Mar 2026
EVE Health Group has completed R&D on multiple reformulated drug candidates targeting major sexual health and cardiovascular markets, preparing patent filings and licensing strategies to capitalise on a combined $30 billion global opportunity.
Ada Torres
Ada Torres
10 Mar 2026
Micro-X has reached a key development milestone with the completion of its first Full Body CT laboratory test bench, securing a $1.6 million payment from US government partner ARPA-H and advancing its innovative medical imaging program.
Victor Sage
Victor Sage
10 Mar 2026
Queste Communications Ltd reported a positive net cash flow from operating activities for February 2026, supported by a robust cash balance and stable financing arrangements. The company’s consolidated position, including its majority stake in Orion Equities, underscores its solid liquidity outlook.
Claire Turing
Claire Turing
9 Mar 2026
OM Holdings has declared a special dividend following the sale of its 26% interest in Ntsimbintle Mining, signalling a strategic return of capital to shareholders.
Maxwell Dee
Maxwell Dee
9 Mar 2026
Cyclopharm Limited has responded to ASX queries clarifying the material significance of its Technegas® contract with the US National Institutes of Health, while confirming robust progress in expanding its US footprint.
Ada Torres
Ada Torres
9 Mar 2026
Island Pharmaceuticals has partnered with the Burnet Institute to explore new antiviral applications for its lead drugs, targeting measles, chikungunya, and Ross River virus. This collaboration leverages existing data and government funding to enhance the company’s clinical pipeline without major capital outlay.
Ada Torres
Ada Torres
9 Mar 2026
A new clinical study from Sichuan University confirms that TruScreen’s AI-enabled cervical cancer screening combined with high-risk HPV testing outperforms traditional cytology methods, reinforcing its global potential.
Ada Torres
Ada Torres
9 Mar 2026
Pro Medicus Limited’s U.S. subsidiary has locked in two significant 5-year contract renewals worth a combined minimum of A$40 million, reinforcing its position in the competitive medical imaging market.
Ada Torres
Ada Torres
9 Mar 2026
Spenda Limited has successfully raised $1.4 million through a private placement, supported by both new and existing sophisticated investors, including key directors. The funds will fuel the company’s commercialisation efforts and strengthen its working capital position.
Sophie Babbage
Sophie Babbage
6 Mar 2026